#gene editing
Aug 2026
Optimization of CRISPR dCas9 Lentiviral Transduction in Nucleus Pulposus Cells for Use in Tissue Engineering.
An optimized protocol balancing high transfection/transduction efficiency with minimized cytotoxicity was developed, supporting tissue-engineered IVD constructs and other CRISPR-based regenerative therapies for DDD.
Evan Davison Kotler, Sajjad Ashraf, J. Santerre et al.
· Tissue Engineering. Part C,... · 0 citations